Vaccination Record Id: RDB01-Composition Identifier: urn:ietf:rfc:3986#urn:uuid:df06d24d-2f22-4315-a610-b780539fb627 Status: Final Code: Immunization record (http://snomed.info/sct#41000179103) Patient: Patient/TC-patient Wegmueller Monika Date: December 10, 2021 Authors: Patient/TC-patient Wegmueller Monika Confidentiality: null Normal (qualifier value) (http://snomed.info/sct#17621005) Sections: Immunization Administration Allergies
Code: Hx of Immunization (http://loinc.org#11369-6) Entries: Immunization/TCB01-IMMUN1 Immunization/TCB01-IMMUN2
Allergies and adverse reactions Document
Code: Allergies and adverse reactions Document (http://loinc.org#48765-2) Entries: AllergyIntolerance/TCB01-ALLINTO1
Generated Narrative: Patient TC-patient Profile: CH Core Patient EPR Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number) Contact Detail ph: tel:+41.32.685.12.34(Home) Leidensweg 10 Specimendorf 9876 CH
Generated Narrative: Practitioner TC-HCP1-C1 Profile: CH Core Practitioner EPR identifier: GLN/7601888888884 active: true name: Peter Müller telecom: ph: tel:+41.32.234.55.66(Work), mailto:allzeit.bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch address: Grabenstrasse 2 Zürich 8005 CH
Generated Narrative: Organization TC-ORG1 Profile: CH Core Organization EPR identifier: GLN/7601777777718 name: Gruppenpraxis Müller telecom: ph: tel:+41.32.234.55.66(Work), mailto:bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch address: Grabenstrasse 2 Zürich ZH 8005 CH
Generated Narrative: PractitionerRole TC-HCP1-ORG1-ROLE-performer Profile: CH Core PractitionerRole EPR active: true practitioner: Practitioner Peter Müller organization: Organization Gruppenpraxis Müller
Generated Narrative: PractitionerRole TC-HCP1-ORG1-ROLE-author Profile: CH Core PractitionerRole EPR active: true practitioner: Practitioner Peter Müller organization: Organization Gruppenpraxis Müller
Generated Narrative: Immunization TCB01-IMMUN1 Profile: CH VACD Immunization Author of the content: PractitionerRole CH VACD Extension Immunization Medication Reference: Medication FSME-IMMUN CC Inj Susp sep Nadel CH VACD Extension verificationStatus: SNOMED CT 59156000: Confirmed identifier: urn:oid:2.999.1.2.3.4/urn:uuid:4386ca26-6866-4322-a203-b488b84ab499 status: Completed vaccineCode: FSME-Immun CC patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number) occurrence: 2021-06-22 recorded: 2021-06-22 11:00:00+0200 lotNumber: 12-34244 route: Intramuscular use Performers - Actor * PractitionerRole ProtocolApplieds - TargetDisease DoseNumber[x] * Tickborne encephalitis 1
Generated Narrative: Medication TC-IMMUN-MEDIC-FSMEIMMCC Profile: CH VACD Medication For Immunization identifier: urn:oid:2.999.1.2.3.4/01194ac7-70ad-4259-b5f4-c5ff0c1b40c5 code: FSME-IMMUN CC Inj Susp sep Nadel status: Active manufacturer: Organization Pfizer AG form: Suspension for injection amount: 0.5 milliliter (Details: UCUM codemL = 'mL')/1 Syringe (unit of presentation) (Details: SNOMED CT code733020007 = 'Syringe') Ingredients - Item[x] * Immunologic substance (substance) Batches - LotNumber * VNR1T10C
Generated Narrative: Organization TC-ORG-PFIZER Profile: CH Core Organization identifier: GLN/7601001010604 name: Pfizer AG telecom: ph: tel:+41 800 562 825(Work), fax: fax:+41 44 583 07 00(Work), mailto:customer.ch@pfizer.com, https://www.pfizer.ch address: Schärenmoosstrasse 99 Postfach Zürich ZH 8052 CH
Generated Narrative: Immunization TCB01-IMMUN2 Profile: CH VACD Immunization Author of the content: PractitionerRole CH VACD Extension Immunization Medication Reference: Medication BOOSTRIX Inj Susp CH VACD Extension verificationStatus: SNOMED CT 59156000: Confirmed identifier: urn:oid:2.999.1.2.3.4/urn:uuid:ebcf6de2-ed9c-463c-8b08-cb487af8ce4e status: Completed vaccineCode: Boostrix patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number) occurrence: 2020-12-09 recorded: 2020-12-09 11:00:00+0200 lotNumber: AHAVB946A route: Intramuscular use Performers - Actor * PractitionerRole protocolApplied targetDisease: Tetanus (disorder), Pertussis (disorder), Diphtheria caused by Corynebacterium diphtheriae (disorder) doseNumber: 1
Diphtheria caused by Corynebacterium diphtheriae (disorder)
Generated Narrative: Medication TC-IMMUN-MEDIC-BOOSTRIX Profile: CH VACD Medication For Immunization identifier: urn:oid:2.999.1.2.3.4/ead68e47-34a6-4534-a658-b718e565fb91 code: BOOSTRIX Inj Susp status: Active manufacturer: Organization GlaxoSmithKline AG form: Suspension for injection amount: 0.5 milliliter (Details: UCUM codemL = 'mL')/1 Syringe (unit of presentation) (Details: SNOMED CT code733020007 = 'Syringe') Ingredients - Item[x] * Immunologic substance (substance) Batches - LotNumber * AHAVB946A
Generated Narrative: Organization TC-ORG-GSK Profile: CH Core Organization identifier: GLN/7601001000674 name: GlaxoSmithKline AG telecom: ph: tel:+41 31 862 21 11(Work), fax: fax:+41 31 862 22 00(Work), mailto:swiss.info@gsk.com, https://www.gsk.com address: Talstrasse 3-5 Münchenbuchsee BE 3053 CH
Generated Narrative: AllergyIntolerance TCB01-ALLINTO1 Profile: CH VACD AllergyIntolerance identifier: urn:oid:2.999.1.2.3.4/00476f5f-f3b7-4e49-9b52-5ec88d65c18e clinicalStatus: Active verificationStatus: Confirmed code: Adverse reaction to component of vaccine product containing Salmonella enterica subspecies enterica serovar Typhi antigen (disorder) patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number) onset: 2021-10-06 recordedDate: 2021-10-06 recorder: PractitionerRole lastOccurrence: 2021-10-06
Adverse reaction to component of vaccine product containing Salmonella enterica subspecies enterica serovar Typhi antigen (disorder)